We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (292)
- COVID-19 (164)
- Safety monitoring and information (120)
- Compliance and enforcement (93)
- Legislation (78)
- Manufacturing (60)
- Vaping hub (57)
- Labelling and packaging (43)
- Import and export (38)
- Medicinal cannabis hub (28)
- Scheduling (national classification system) (27)
- Sunscreens (20)
- Weight loss products (18)
- Shortages and supply disruptions (11)
- Committees and advisory bodies (9)
- Cosmetics (6)
- Unique Device Identification (UDI) hub (5)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1294 result(s) found, displaying 501 to 525
-
News articlesThe Prescribing Medicines in Pregnancy database has now been updated.
-
News articlesThe Generic Medicines Work-Sharing Initiative has updated its Operational Procedures document and Expression Of Interest form.
-
Media releasesTravellers will be able to bring up to 3-months supply of their medicine.
-
Therapeutic Goods (Biologicals-Application Form for Priority Applicant Determinations) Approval 2022
Regulatory decision noticesApproval of the Therapeutic Goods (Biologicals—Application Form for Priority Applicant Determinations) -
News articlesBefore you take a weight loss supplement or medicine, there are things to consider.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
BlogMake small changes to how you think about paracetamol.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products in Australia.
-
News articlesA warning to social media influencers and advertisers not to advertise this prescription medicine.
-
Regulatory decision noticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.
-
Media releasesThe TGA has issued an infringement notice of $2,664 to a NSW-based medical practitioner for alleged unlawful advertising of nicotine vaping products in a social media post.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has granted a provisional determination to Pfizer's bivalent COVID-19 vaccine candidate: tozinameran & famtozinameran (COMIRNATY BIVALENT OMICRON BA.4/BA.5 COVID-19 VACCINE).
-
Regulatory decision noticesArrangement under subsection 7C(1) of the Therapeutic Goods Act 1989 for use of computer programs to make decisions under sections 61(3)(a), 61(5AA), and 61(5AB) of the Act
-
Media releasesOn 25 October 2022, Natural Franchises Pty Ltd pleaded guilty in a Sydney court to over 200 offences of the Therapeutic Goods Act 1989 for the manufacture, supply and advertising of unapproved therapeutic goods.
-
Media releasesThe TGA is calling for anyone using a Philips Continuous Positive Airway Pressure (CPAP) machine or a Bi-level Positive Airway Pressure (Bi-Level PAP) machine to see if they are affected by the recall action.
-
Regulatory decision noticesThis instrument is the Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Pfizer) (Tozinameran and Riltozinameran) Labelling Exemption 2022.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
News articlesFind out about the requirements starting on 1 January 2023 for medicines that are serialised or include a data matrix code.
-
Media releasesThe TGA has issued one infringement notice to Queensland-based IMUNI Pty Ltd for allegedly advertising a complementary medicine for a therapeutic use that was not permitted.
-
Safety updatesMedicines Safety Update - Information for health professionals.
-
Media releasesThe TGA has issued infringement notices for the alleged unlawful advertising of medicinal cannabis products on a website and through social media.
-
Media releasesThe TGA has issued infringement notices for the alleged unlawful advertising of medicinal cannabis products on their websites and social media platforms.